Will edison (Talk | contribs) |
Will edison (Talk | contribs) |
||
Line 142: | Line 142: | ||
<!-- Classic Heading --> | <!-- Classic Heading --> | ||
<div class="col-md-9"> | <div class="col-md-9"> | ||
− | + | ||
<div class="row"> | <div class="row"> | ||
<div class="col-md-12" style="margin:0px; padding:0"> | <div class="col-md-12" style="margin:0px; padding:0"> | ||
Line 157: | Line 157: | ||
</div> | </div> | ||
− | + | ||
<div class="col-md-12" style="margin:0px; padding:0"> | <div class="col-md-12" style="margin:0px; padding:0"> | ||
+ | <div class="row"> | ||
<h3 class="classic-title" style="margin-top:0px"><span>Parts List</span></h3> | <h3 class="classic-title" style="margin-top:0px"><span>Parts List</span></h3> | ||
Revision as of 15:41, 18 October 2016
Favorite Parts
BBa_K1922006
- With the combination of hTert promoter and p53, if we deliver the plasmid into mouse by virus packaging, p53 will be overexpressed in tumor cells specifically, so the thermosensitivity of tumor cells would be increased rather than of normal cells. When tumor is treated by laser with certain-length wave, with the heat induced by our golden nano rods(GNRs), the apoptosis of tumor cells whose thermosensitivity has been increased would start more efficiently. Thus, because of the tumor-targeted hTert promoter and the tumor suppressor following it, we improved the targeting of conventional thermotherapy.
Parts List
Favorite | Name | Type | Description | Length |
---|---|---|---|---|
√ | BBa_K1922006 | Composite | hTert-p53 | 1953 |
BBa_K1922007 | Composite | hsp70-p53 | 1667 | |
BBa_K1922012 | Composite | hsp70-p53-luciferase | 2666 | |
BBa_K1922009 | Composite | hTert-GFP | 1488 | |
BBa_K1922001 | regulatory | hTert promoter | 765 | |
BBa_K1922004 | regulatory | (hsp70 promoter) pro-moter | 477 | |
BBa_K1922008 | reporter | Green fluorescent protein | 717 | |
BBa_K1922010 | reporter | Green fluorescent protein | 993 | |
BBa_K1922003 | coding | coding for tumor supressor, wild type p53 | 993 |